LFB is a prominent French biopharmaceutical group that specializes in the development, manufacturing, and commercialization of plasma-derived medicinal products. As a major player in the field of therapeutic proteins, LFB plays a vital role in medical care by providing essential treatments for patients with rare and severe conditions in the fields of immunology, hemostasis, and intensive care.
Driven by a mission to improve patient quality of life, the company integrates the entire value chain from plasma collection management to state-of-the-art biological manufacturing. With a strong commitment to innovation and research, LFB continues to advance the future of medicine through sophisticated biotechnology and a dedicated team of professionals focused on excellence.